Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

Index by author

April 01, 2001; Volume 28,Issue 4
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Aceves-Avila, F J

    1. You have access
      The antiquity of rheumatoid arthritis: a reappraisal.
      F J Aceves-Avila, F Medina and A Fraga
      The Journal of Rheumatology April 1 2001, 28 (4) 751-757;
  2. Acquista, C A

    1. You have access
      Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report.
      F P Cantatore, C A Acquista, A Corrado, F Iannone and G Lapadula
      The Journal of Rheumatology April 1 2001, 28 (4) 922-924;
  3. Adamopoulos, G K

    1. You have access
      How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study.
      K A Boki, J P Ioannidis, J V Segas, P V Maragkoudakis, D Petrou, G K Adamopoulos and H M Moutsopoulos
      The Journal of Rheumatology April 1 2001, 28 (4) 798-801;
  4. Agarwal, V

    1. You have access
      Primary patellar T cell lymphoma: an unusual cause of monoarthritis.
      V Agarwal, L Pal, A Aggarwal and R Misra
      The Journal of Rheumatology April 1 2001, 28 (4) 876-877;
  5. Aggarwal, A

    1. You have access
      Primary patellar T cell lymphoma: an unusual cause of monoarthritis.
      V Agarwal, L Pal, A Aggarwal and R Misra
      The Journal of Rheumatology April 1 2001, 28 (4) 876-877;
  6. Allevi, E

    1. You have access
      Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;
  7. Alvarez-Blanco, M J

    1. You have access
      Glucocorticoids but not NSAID abort attacks in hyper-IgD and periodic fever syndrome.
      J de Dios García-Díaz and M J Alvarez-Blanco
      The Journal of Rheumatology April 1 2001, 28 (4) 925-926;
  8. Arnold, S

    1. You have access
      Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;
  9. Asherson, R A

    1. You have access
      The clinical significance of IgA antiphospholipid antibodies.
      M Samarkos, R A Asherson and S Loizou
      The Journal of Rheumatology April 1 2001, 28 (4) 694-697;
  10. Athreya, B H

    1. You have access
      Point prevalence of cardiac abnormalities in children with systemic lupus erythematosus.
      J P Guevara, B J Clark and B H Athreya
      The Journal of Rheumatology April 1 2001, 28 (4) 854-859;

B

  1. Badley, E

    1. You have access
      Arthritis and rheumatism are neglected health priorities: a bibliometric study.
      R Glazier, J Fry and E Badley
      The Journal of Rheumatology April 1 2001, 28 (4) 706-711;
  2. Bernareggi, M

    1. You have access
      Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;
  3. Boers, M

    1. You have access
      High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis.
      R J Verburg, J K Sont, T P Vliet Vlieland, R B Landewé, M Boers, J Kievit and J M van Laar
      The Journal of Rheumatology April 1 2001, 28 (4) 719-727;
    2. You have access
      Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agenda.
      V Strand, M Lassere, D van der Heijde, K Johnson and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 887-889;
    3. You have access
      Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials.
      M N Lassere, D van der Heijde, K R Johnson, M Boers and J Edmonds
      The Journal of Rheumatology April 1 2001, 28 (4) 892-903;
    4. You have access
      Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;
    5. You have access
      Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;
    6. You have access
      Minimal clinically important difference in plain films in RA: group discussions, conclusions, and recommendations. OMERACT Imaging Task Force.
      D van der Heijde, M Lassere, J Edmonds, J Kirwan, V Strand and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 914-917;
  4. Boki, K A

    1. You have access
      How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study.
      K A Boki, J P Ioannidis, J V Segas, P V Maragkoudakis, D Petrou, G K Adamopoulos and H M Moutsopoulos
      The Journal of Rheumatology April 1 2001, 28 (4) 798-801;
  5. Bonfá, E

    1. You have access
      Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy.
      E F Borba and E Bonfá
      The Journal of Rheumatology April 1 2001, 28 (4) 780-785;
  6. Boonen, A

    1. You have access
      Muhammad Asim Khan. Portrait of a rheumatologist as a great artist.
      A Boonen, D van der Heijde and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 843-844;
    2. You have access
      Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;
    3. You have access
      Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;
  7. Borba, E F

    1. You have access
      Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy.
      E F Borba and E Bonfá
      The Journal of Rheumatology April 1 2001, 28 (4) 780-785;
  8. Bottasso, B

    1. You have access
      Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;
  9. Bresnihan, B

    1. You have access
      A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor.
      M Doran, P Wordsworth, B Bresnihan and O Fitzgerald
      The Journal of Rheumatology April 1 2001, 28 (4) 921-922;
  10. Brooks, C D

    1. You have access
      Sulfasalazine for the management of juvenile rheumatoid arthritis.
      C D Brooks
      The Journal of Rheumatology April 1 2001, 28 (4) 845-853;
  11. Bruynesteyn, K

    1. You have access
      Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;
    2. You have access
      Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;
  12. Buchanan, W W

    1. You have access
      Rheumatoid arthritis: beyond the lymphocyte.
      W W Buchanan and W F Kean
      The Journal of Rheumatology April 1 2001, 28 (4) 691-693;
  13. Buratti, S

    1. You have access
      Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
      A Ravelli, M C Caria, S Buratti, C Malattia, F Temporini and A Martini
      The Journal of Rheumatology April 1 2001, 28 (4) 865-867;
  14. Burkhardt, D

    1. You have access
      The effects of orally administered diacerein on cartilage and subchondral bone in an ovine model of osteoarthritis.
      S Y Hwa, D Burkhardt, C Little and P Ghosh
      The Journal of Rheumatology April 1 2001, 28 (4) 825-834;

C

  1. Cantatore, F P

    1. You have access
      Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report.
      F P Cantatore, C A Acquista, A Corrado, F Iannone and G Lapadula
      The Journal of Rheumatology April 1 2001, 28 (4) 922-924;
  2. Cantini, F

    1. You have access
      Magnetic resonance imaging and polymyalgia rheumatica.
      C Salvarini, F Cantini, I Olivieri and G G Hunder
      The Journal of Rheumatology April 1 2001, 28 (4) 918-919;
  3. Caria, M C

    1. You have access
      Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
      A Ravelli, M C Caria, S Buratti, C Malattia, F Temporini and A Martini
      The Journal of Rheumatology April 1 2001, 28 (4) 865-867;
  4. Casado, E

    1. You have access
      Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
      E Casado, A Olivé, S Holgado, R Perez-Andres, J Romeu, J C Lorenzo, B Clotet and X Tena
      The Journal of Rheumatology April 1 2001, 28 (4) 802-804;
  5. Catena, L

    1. You have access
      Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;
  6. Chang, M

    1. You have access
      DNA microsatellite markers for estrogen receptor-beta are not associated with systemic lupus erythematosus.
      M Chang, D B Lubahn and R W Hoffman
      The Journal of Rheumatology April 1 2001, 28 (4) 924-925;
  7. Chaudhry-Ahluwalia, V

    1. You have access
      Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus.
      D D Gladman, M B Urowitz, V Chaudhry-Ahluwalia, D C Hallet and R J Cook
      The Journal of Rheumatology April 1 2001, 28 (4) 761-765;
  8. Clark, B J

    1. You have access
      Point prevalence of cardiac abnormalities in children with systemic lupus erythematosus.
      J P Guevara, B J Clark and B H Athreya
      The Journal of Rheumatology April 1 2001, 28 (4) 854-859;
  9. Clark-Soloninka, C A

    1. You have access
      In vitro thrombin generation.
      C A Clark-Soloninka and C A Laskin
      The Journal of Rheumatology April 1 2001, 28 (4) 919-920;
  10. Clotet, B

    1. You have access
      Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
      E Casado, A Olivé, S Holgado, R Perez-Andres, J Romeu, J C Lorenzo, B Clotet and X Tena
      The Journal of Rheumatology April 1 2001, 28 (4) 802-804;
  11. Cook, R J

    1. You have access
      Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus.
      D D Gladman, M B Urowitz, V Chaudhry-Ahluwalia, D C Hallet and R J Cook
      The Journal of Rheumatology April 1 2001, 28 (4) 761-765;
  12. Corrado, A

    1. You have access
      Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report.
      F P Cantatore, C A Acquista, A Corrado, F Iannone and G Lapadula
      The Journal of Rheumatology April 1 2001, 28 (4) 922-924;
  13. Coyle, D

    1. You have access
      Treatment related mortality versus quality of life--a balancing act.
      R J McKendry and D Coyle
      The Journal of Rheumatology April 1 2001, 28 (4) 688-690;
  14. Cugno, M

    1. You have access
      Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;

D

  1. de Dios García-Díaz, J

    1. You have access
      Glucocorticoids but not NSAID abort attacks in hyper-IgD and periodic fever syndrome.
      J de Dios García-Díaz and M J Alvarez-Blanco
      The Journal of Rheumatology April 1 2001, 28 (4) 925-926;
  2. de Jong, Z

    1. You have access
      The value of a continuous ambulatory activity monitor to quantify the amount and intensity of daily activity in patients with rheumatoid arthritis.
      M Munneke, Z de Jong, A H Zwinderman, G J Tijhuis, J M Hazes and T P Vliet Vlieland
      The Journal of Rheumatology April 1 2001, 28 (4) 745-750;
  3. Di Battista, J A

    1. You have access
      Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.
      D V Jovanovic, J A Di Battista, J Martel-Pelletier, P Reboul, Y He, F C Jolicoeur and J P Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 712-718;
  4. Doran, M

    1. You have access
      A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor.
      M Doran, P Wordsworth, B Bresnihan and O Fitzgerald
      The Journal of Rheumatology April 1 2001, 28 (4) 921-922;

E

  1. Edmonds, J

    1. You have access
      Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials.
      M N Lassere, D van der Heijde, K R Johnson, M Boers and J Edmonds
      The Journal of Rheumatology April 1 2001, 28 (4) 892-903;
    2. You have access
      Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;
    3. You have access
      Minimal clinically important difference in plain films in RA: group discussions, conclusions, and recommendations. OMERACT Imaging Task Force.
      D van der Heijde, M Lassere, J Edmonds, J Kirwan, V Strand and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 914-917;
  2. Emery, P

    1. You have access
      Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;
  3. Erben, R G

    1. You have access
      Osteoprotegerin, RANK, and RANK ligand: the good, the bad, and the ugly in rheumatoid arthritis.
      L C Hofbauer, A E Heufelder and R G Erben
      The Journal of Rheumatology April 1 2001, 28 (4) 685-687;

F

  1. Fernandes, J C

    1. You have access
      Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone.
      J P Pelletier, D Lajeunesse, P Reboul, F Mineau, J C Fernandes, P Sabouret and J Martel-Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 814-824;
  2. Fitzgerald, O

    1. You have access
      A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor.
      M Doran, P Wordsworth, B Bresnihan and O Fitzgerald
      The Journal of Rheumatology April 1 2001, 28 (4) 921-922;
  3. Fraga, A

    1. You have access
      The antiquity of rheumatoid arthritis: a reappraisal.
      F J Aceves-Avila, F Medina and A Fraga
      The Journal of Rheumatology April 1 2001, 28 (4) 751-757;
  4. Fry, J

    1. You have access
      Arthritis and rheumatism are neglected health priorities: a bibliometric study.
      R Glazier, J Fry and E Badley
      The Journal of Rheumatology April 1 2001, 28 (4) 706-711;

G

  1. Gardinali, M

    1. You have access
      Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;
  2. Geirsson, A J

    1. You have access
      Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study.
      S Saevarsdottir, T Vikingsdottir, A Vikingsson, V Manfredsdottir, A J Geirsson and H Valdimarsson
      The Journal of Rheumatology April 1 2001, 28 (4) 728-734;
  3. Ghosh, P

    1. You have access
      The effects of orally administered diacerein on cartilage and subchondral bone in an ovine model of osteoarthritis.
      S Y Hwa, D Burkhardt, C Little and P Ghosh
      The Journal of Rheumatology April 1 2001, 28 (4) 825-834;
  4. Gladman, D D

    1. You have access
      Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus.
      D D Gladman, M B Urowitz, V Chaudhry-Ahluwalia, D C Hallet and R J Cook
      The Journal of Rheumatology April 1 2001, 28 (4) 761-765;
  5. Glazier, R

    1. You have access
      Arthritis and rheumatism are neglected health priorities: a bibliometric study.
      R Glazier, J Fry and E Badley
      The Journal of Rheumatology April 1 2001, 28 (4) 706-711;
  6. Goldman, J A

    1. You have access
      Fibromyalgia and hypermobility.
      J A Goldman
      The Journal of Rheumatology April 1 2001, 28 (4) 920-921;
  7. Guevara, J P

    1. You have access
      Point prevalence of cardiac abnormalities in children with systemic lupus erythematosus.
      J P Guevara, B J Clark and B H Athreya
      The Journal of Rheumatology April 1 2001, 28 (4) 854-859;
  8. Gumanovskaya, M L

    1. You have access
      Regulation of cartilage collagenase by doxycycline.
      B V Shlopov, J M Stuart, M L Gumanovskaya and K A Hasty
      The Journal of Rheumatology April 1 2001, 28 (4) 835-842;

H

  1. Haas-Smith, S A

    1. You have access
      Expression of interleukin 10 mRNA and protein by synovial fibroblastoid cells.
      C Ritchlin and S A Haas-Smith
      The Journal of Rheumatology April 1 2001, 28 (4) 698-705;
  2. Hall, C

    1. You have access
      Unusual presentation of polyarteritis nodosa.
      C Hall and A B Mongey
      The Journal of Rheumatology April 1 2001, 28 (4) 871-873;
  3. Hallet, D C

    1. You have access
      Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus.
      D D Gladman, M B Urowitz, V Chaudhry-Ahluwalia, D C Hallet and R J Cook
      The Journal of Rheumatology April 1 2001, 28 (4) 761-765;
  4. Hamada, J

    1. You have access
      Analysis of calcium deposits in calcific periarthritis.
      J Hamada, W Ono, K Tamai, K Saotome and T Hoshino
      The Journal of Rheumatology April 1 2001, 28 (4) 809-813;
  5. Häntzschel, H

    1. You have access
      Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;
  6. Hasty, K A

    1. You have access
      Regulation of cartilage collagenase by doxycycline.
      B V Shlopov, J M Stuart, M L Gumanovskaya and K A Hasty
      The Journal of Rheumatology April 1 2001, 28 (4) 835-842;
  7. Hayashi, Y

    1. You have access
      Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
      N Maeno, S Takei, H Imanaka, H Oda, K Yanagi, Y Hayashi and K Miyata
      The Journal of Rheumatology April 1 2001, 28 (4) 860-864;
  8. Hazes, J M

    1. You have access
      The value of a continuous ambulatory activity monitor to quantify the amount and intensity of daily activity in patients with rheumatoid arthritis.
      M Munneke, Z de Jong, A H Zwinderman, G J Tijhuis, J M Hazes and T P Vliet Vlieland
      The Journal of Rheumatology April 1 2001, 28 (4) 745-750;
  9. He, Y

    1. You have access
      Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.
      D V Jovanovic, J A Di Battista, J Martel-Pelletier, P Reboul, Y He, F C Jolicoeur and J P Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 712-718;
  10. Heufelder, A E

    1. You have access
      Osteoprotegerin, RANK, and RANK ligand: the good, the bad, and the ugly in rheumatoid arthritis.
      L C Hofbauer, A E Heufelder and R G Erben
      The Journal of Rheumatology April 1 2001, 28 (4) 685-687;
  11. Hofbauer, L C

    1. You have access
      Osteoprotegerin, RANK, and RANK ligand: the good, the bad, and the ugly in rheumatoid arthritis.
      L C Hofbauer, A E Heufelder and R G Erben
      The Journal of Rheumatology April 1 2001, 28 (4) 685-687;
  12. Hoffman, R W

    1. You have access
      DNA microsatellite markers for estrogen receptor-beta are not associated with systemic lupus erythematosus.
      M Chang, D B Lubahn and R W Hoffman
      The Journal of Rheumatology April 1 2001, 28 (4) 924-925;
  13. Holgado, S

    1. You have access
      Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
      E Casado, A Olivé, S Holgado, R Perez-Andres, J Romeu, J C Lorenzo, B Clotet and X Tena
      The Journal of Rheumatology April 1 2001, 28 (4) 802-804;
  14. Hoshino, T

    1. You have access
      Analysis of calcium deposits in calcific periarthritis.
      J Hamada, W Ono, K Tamai, K Saotome and T Hoshino
      The Journal of Rheumatology April 1 2001, 28 (4) 809-813;
  15. Houben, H

    1. You have access
      Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;
  16. Hunder, G G

    1. You have access
      Magnetic resonance imaging and polymyalgia rheumatica.
      C Salvarini, F Cantini, I Olivieri and G G Hunder
      The Journal of Rheumatology April 1 2001, 28 (4) 918-919;
  17. Husby, G

    1. You have access
      Somatic and psychological features of headache in systemic lupus erythematosus.
      R Omdal, K Waterloo, W Koldingsnes, G Husby and S I Mellgren
      The Journal of Rheumatology April 1 2001, 28 (4) 772-779;
  18. Hwa, S Y

    1. You have access
      The effects of orally administered diacerein on cartilage and subchondral bone in an ovine model of osteoarthritis.
      S Y Hwa, D Burkhardt, C Little and P Ghosh
      The Journal of Rheumatology April 1 2001, 28 (4) 825-834;

I

  1. Iannone, F

    1. You have access
      Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report.
      F P Cantatore, C A Acquista, A Corrado, F Iannone and G Lapadula
      The Journal of Rheumatology April 1 2001, 28 (4) 922-924;
  2. Imanaka, H

    1. You have access
      Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
      N Maeno, S Takei, H Imanaka, H Oda, K Yanagi, Y Hayashi and K Miyata
      The Journal of Rheumatology April 1 2001, 28 (4) 860-864;
  3. Ioannidis, J P

    1. You have access
      How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study.
      K A Boki, J P Ioannidis, J V Segas, P V Maragkoudakis, D Petrou, G K Adamopoulos and H M Moutsopoulos
      The Journal of Rheumatology April 1 2001, 28 (4) 798-801;

J

  1. Johnson, K

    1. You have access
      Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agenda.
      V Strand, M Lassere, D van der Heijde, K Johnson and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 887-889;
    2. You have access
      Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;
  2. Johnson, K R

    1. You have access
      Foundations of the minimal clinically important difference for imaging.
      M N Lassere, D van der Heijde and K R Johnson
      The Journal of Rheumatology April 1 2001, 28 (4) 890-891;
    2. You have access
      Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials.
      M N Lassere, D van der Heijde, K R Johnson, M Boers and J Edmonds
      The Journal of Rheumatology April 1 2001, 28 (4) 892-903;
  3. Jolicoeur, F C

    1. You have access
      Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.
      D V Jovanovic, J A Di Battista, J Martel-Pelletier, P Reboul, Y He, F C Jolicoeur and J P Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 712-718;
  4. Jovanovic, D V

    1. You have access
      Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.
      D V Jovanovic, J A Di Battista, J Martel-Pelletier, P Reboul, Y He, F C Jolicoeur and J P Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 712-718;
  5. Julkunen, H

    1. You have access
      Familial systemic lupus erythematosus in Finland.
      S Koskenmies, E Widen, J Kere and H Julkunen
      The Journal of Rheumatology April 1 2001, 28 (4) 758-760;

K

  1. Kaltenhäuser, S

    1. You have access
      Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;
  2. Kean, W F

    1. You have access
      Rheumatoid arthritis: beyond the lymphocyte.
      W W Buchanan and W F Kean
      The Journal of Rheumatology April 1 2001, 28 (4) 691-693;
  3. Kere, J

    1. You have access
      Familial systemic lupus erythematosus in Finland.
      S Koskenmies, E Widen, J Kere and H Julkunen
      The Journal of Rheumatology April 1 2001, 28 (4) 758-760;
  4. Kesavan, R B

    1. You have access
      Systemic lupus erythematosus presenting as "one-and-a-half syndrome".
      C Kunavarapu, R B Kesavan, M Pevil-Ulysee and S S Mohan
      The Journal of Rheumatology April 1 2001, 28 (4) 874-875;
  5. Khan, W

    1. You have access
      Treatment of Felty's syndrome with leflunomide.
      F Talip, N Walker, W Khan and B Zimmermann
      The Journal of Rheumatology April 1 2001, 28 (4) 868-870;
  6. Kievit, J

    1. You have access
      High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis.
      R J Verburg, J K Sont, T P Vliet Vlieland, R B Landewé, M Boers, J Kievit and J M van Laar
      The Journal of Rheumatology April 1 2001, 28 (4) 719-727;
  7. Kirwan, J

    1. You have access
      Minimal clinically important difference in plain films in RA: group discussions, conclusions, and recommendations. OMERACT Imaging Task Force.
      D van der Heijde, M Lassere, J Edmonds, J Kirwan, V Strand and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 914-917;
  8. Kirwan, J R

    1. You have access
      Links between radiological change, disability, and pathology in rheumatoid arthritis.
      J R Kirwan
      The Journal of Rheumatology April 1 2001, 28 (4) 881-886;
  9. Koldingsnes, W

    1. You have access
      Somatic and psychological features of headache in systemic lupus erythematosus.
      R Omdal, K Waterloo, W Koldingsnes, G Husby and S I Mellgren
      The Journal of Rheumatology April 1 2001, 28 (4) 772-779;
    2. You have access
      Renal granuloma and glomerulonephritis in Wegener's granulomatosis.
      H Nossent and W Koldingsnes
      The Journal of Rheumatology April 1 2001, 28 (4) 878-879;
  10. Koskenmies, S

    1. You have access
      Familial systemic lupus erythematosus in Finland.
      S Koskenmies, E Widen, J Kere and H Julkunen
      The Journal of Rheumatology April 1 2001, 28 (4) 758-760;
  11. Kunavarapu, C

    1. You have access
      Systemic lupus erythematosus presenting as "one-and-a-half syndrome".
      C Kunavarapu, R B Kesavan, M Pevil-Ulysee and S S Mohan
      The Journal of Rheumatology April 1 2001, 28 (4) 874-875;

L

  1. Lajeunesse, D

    1. You have access
      Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone.
      J P Pelletier, D Lajeunesse, P Reboul, F Mineau, J C Fernandes, P Sabouret and J Martel-Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 814-824;
  2. Landewé, R B

    1. You have access
      High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis.
      R J Verburg, J K Sont, T P Vliet Vlieland, R B Landewé, M Boers, J Kievit and J M van Laar
      The Journal of Rheumatology April 1 2001, 28 (4) 719-727;
  3. Lapadula, G

    1. You have access
      Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report.
      F P Cantatore, C A Acquista, A Corrado, F Iannone and G Lapadula
      The Journal of Rheumatology April 1 2001, 28 (4) 922-924;
  4. Laskin, C A

    1. You have access
      In vitro thrombin generation.
      C A Clark-Soloninka and C A Laskin
      The Journal of Rheumatology April 1 2001, 28 (4) 919-920;
  5. Lassere, M

    1. You have access
      Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agenda.
      V Strand, M Lassere, D van der Heijde, K Johnson and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 887-889;
    2. You have access
      Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;
    3. You have access
      Minimal clinically important difference in plain films in RA: group discussions, conclusions, and recommendations. OMERACT Imaging Task Force.
      D van der Heijde, M Lassere, J Edmonds, J Kirwan, V Strand and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 914-917;
  6. Lassere, M N

    1. You have access
      Foundations of the minimal clinically important difference for imaging.
      M N Lassere, D van der Heijde and K R Johnson
      The Journal of Rheumatology April 1 2001, 28 (4) 890-891;
    2. You have access
      Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials.
      M N Lassere, D van der Heijde, K R Johnson, M Boers and J Edmonds
      The Journal of Rheumatology April 1 2001, 28 (4) 892-903;
    3. You have access
      Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;
  7. Lau, C S

    1. You have access
      Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
      C C Mok, C S Lau and R W Wong
      The Journal of Rheumatology April 1 2001, 28 (4) 766-771;
  8. Little, C

    1. You have access
      The effects of orally administered diacerein on cartilage and subchondral bone in an ovine model of osteoarthritis.
      S Y Hwa, D Burkhardt, C Little and P Ghosh
      The Journal of Rheumatology April 1 2001, 28 (4) 825-834;
  9. Loeffler, M

    1. You have access
      Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;
  10. Loizou, S

    1. You have access
      The clinical significance of IgA antiphospholipid antibodies.
      M Samarkos, R A Asherson and S Loizou
      The Journal of Rheumatology April 1 2001, 28 (4) 694-697;
  11. Lorenzo, J C

    1. You have access
      Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
      E Casado, A Olivé, S Holgado, R Perez-Andres, J Romeu, J C Lorenzo, B Clotet and X Tena
      The Journal of Rheumatology April 1 2001, 28 (4) 802-804;
  12. Lubahn, D B

    1. You have access
      DNA microsatellite markers for estrogen receptor-beta are not associated with systemic lupus erythematosus.
      M Chang, D B Lubahn and R W Hoffman
      The Journal of Rheumatology April 1 2001, 28 (4) 924-925;

M

  1. Maeno, N

    1. You have access
      Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
      N Maeno, S Takei, H Imanaka, H Oda, K Yanagi, Y Hayashi and K Miyata
      The Journal of Rheumatology April 1 2001, 28 (4) 860-864;
  2. Malattia, C

    1. You have access
      Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
      A Ravelli, M C Caria, S Buratti, C Malattia, F Temporini and A Martini
      The Journal of Rheumatology April 1 2001, 28 (4) 865-867;
  3. Manfredsdottir, V

    1. You have access
      Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study.
      S Saevarsdottir, T Vikingsdottir, A Vikingsson, V Manfredsdottir, A J Geirsson and H Valdimarsson
      The Journal of Rheumatology April 1 2001, 28 (4) 728-734;
  4. Maragkoudakis, P V

    1. You have access
      How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study.
      K A Boki, J P Ioannidis, J V Segas, P V Maragkoudakis, D Petrou, G K Adamopoulos and H M Moutsopoulos
      The Journal of Rheumatology April 1 2001, 28 (4) 798-801;
  5. Martel-Pelletier, J

    1. You have access
      Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.
      D V Jovanovic, J A Di Battista, J Martel-Pelletier, P Reboul, Y He, F C Jolicoeur and J P Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 712-718;
    2. You have access
      Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone.
      J P Pelletier, D Lajeunesse, P Reboul, F Mineau, J C Fernandes, P Sabouret and J Martel-Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 814-824;
  6. Martini, A

    1. You have access
      Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
      A Ravelli, M C Caria, S Buratti, C Malattia, F Temporini and A Martini
      The Journal of Rheumatology April 1 2001, 28 (4) 865-867;
  7. McKendry, R J

    1. You have access
      Treatment related mortality versus quality of life--a balancing act.
      R J McKendry and D Coyle
      The Journal of Rheumatology April 1 2001, 28 (4) 688-690;
  8. Medina, F

    1. You have access
      The antiquity of rheumatoid arthritis: a reappraisal.
      F J Aceves-Avila, F Medina and A Fraga
      The Journal of Rheumatology April 1 2001, 28 (4) 751-757;
  9. Mellgren, S I

    1. You have access
      Somatic and psychological features of headache in systemic lupus erythematosus.
      R Omdal, K Waterloo, W Koldingsnes, G Husby and S I Mellgren
      The Journal of Rheumatology April 1 2001, 28 (4) 772-779;
  10. Mineau, F

    1. You have access
      Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone.
      J P Pelletier, D Lajeunesse, P Reboul, F Mineau, J C Fernandes, P Sabouret and J Martel-Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 814-824;
  11. Misra, R

    1. You have access
      Primary patellar T cell lymphoma: an unusual cause of monoarthritis.
      V Agarwal, L Pal, A Aggarwal and R Misra
      The Journal of Rheumatology April 1 2001, 28 (4) 876-877;
  12. Miyata, K

    1. You have access
      Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
      N Maeno, S Takei, H Imanaka, H Oda, K Yanagi, Y Hayashi and K Miyata
      The Journal of Rheumatology April 1 2001, 28 (4) 860-864;
  13. Mohan, S S

    1. You have access
      Systemic lupus erythematosus presenting as "one-and-a-half syndrome".
      C Kunavarapu, R B Kesavan, M Pevil-Ulysee and S S Mohan
      The Journal of Rheumatology April 1 2001, 28 (4) 874-875;
  14. Mok, C C

    1. You have access
      Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
      C C Mok, C S Lau and R W Wong
      The Journal of Rheumatology April 1 2001, 28 (4) 766-771;
  15. Molenaar, E

    1. You have access
      Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;
  16. Mongey, A B

    1. You have access
      Unusual presentation of polyarteritis nodosa.
      C Hall and A B Mongey
      The Journal of Rheumatology April 1 2001, 28 (4) 871-873;
  17. Montani, N

    1. You have access
      Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;
  18. Moutsopoulos, H M

    1. You have access
      How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study.
      K A Boki, J P Ioannidis, J V Segas, P V Maragkoudakis, D Petrou, G K Adamopoulos and H M Moutsopoulos
      The Journal of Rheumatology April 1 2001, 28 (4) 798-801;
  19. Munneke, M

    1. You have access
      The value of a continuous ambulatory activity monitor to quantify the amount and intensity of daily activity in patients with rheumatoid arthritis.
      M Munneke, Z de Jong, A H Zwinderman, G J Tijhuis, J M Hazes and T P Vliet Vlieland
      The Journal of Rheumatology April 1 2001, 28 (4) 745-750;

N

  1. Nityanand, S

    1. You have access
      Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis.
      N K Tripathy, S Upadhyaya, N Sinha and S Nityanand
      The Journal of Rheumatology April 1 2001, 28 (4) 805-808;
  2. Nossent, H

    1. You have access
      Renal granuloma and glomerulonephritis in Wegener's granulomatosis.
      H Nossent and W Koldingsnes
      The Journal of Rheumatology April 1 2001, 28 (4) 878-879;

O

  1. Oda, H

    1. You have access
      Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
      N Maeno, S Takei, H Imanaka, H Oda, K Yanagi, Y Hayashi and K Miyata
      The Journal of Rheumatology April 1 2001, 28 (4) 860-864;
  2. Olivé, A

    1. You have access
      Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
      E Casado, A Olivé, S Holgado, R Perez-Andres, J Romeu, J C Lorenzo, B Clotet and X Tena
      The Journal of Rheumatology April 1 2001, 28 (4) 802-804;
  3. Olivieri, I

    1. You have access
      Magnetic resonance imaging and polymyalgia rheumatica.
      C Salvarini, F Cantini, I Olivieri and G G Hunder
      The Journal of Rheumatology April 1 2001, 28 (4) 918-919;
  4. Omdal, R

    1. You have access
      Somatic and psychological features of headache in systemic lupus erythematosus.
      R Omdal, K Waterloo, W Koldingsnes, G Husby and S I Mellgren
      The Journal of Rheumatology April 1 2001, 28 (4) 772-779;
  5. Ono, W

    1. You have access
      Analysis of calcium deposits in calcific periarthritis.
      J Hamada, W Ono, K Tamai, K Saotome and T Hoshino
      The Journal of Rheumatology April 1 2001, 28 (4) 809-813;

P

  1. Pal, L

    1. You have access
      Primary patellar T cell lymphoma: an unusual cause of monoarthritis.
      V Agarwal, L Pal, A Aggarwal and R Misra
      The Journal of Rheumatology April 1 2001, 28 (4) 876-877;
  2. Paulus, H

    1. You have access
      Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;
  3. Pelletier, J P

    1. You have access
      Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.
      D V Jovanovic, J A Di Battista, J Martel-Pelletier, P Reboul, Y He, F C Jolicoeur and J P Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 712-718;
    2. You have access
      Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone.
      J P Pelletier, D Lajeunesse, P Reboul, F Mineau, J C Fernandes, P Sabouret and J Martel-Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 814-824;
  4. Peloso, P

    1. You have access
      Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;
  5. Perez-Andres, R

    1. You have access
      Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
      E Casado, A Olivé, S Holgado, R Perez-Andres, J Romeu, J C Lorenzo, B Clotet and X Tena
      The Journal of Rheumatology April 1 2001, 28 (4) 802-804;
  6. Petrou, D

    1. You have access
      How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study.
      K A Boki, J P Ioannidis, J V Segas, P V Maragkoudakis, D Petrou, G K Adamopoulos and H M Moutsopoulos
      The Journal of Rheumatology April 1 2001, 28 (4) 798-801;
  7. Pevil-Ulysee, M

    1. You have access
      Systemic lupus erythematosus presenting as "one-and-a-half syndrome".
      C Kunavarapu, R B Kesavan, M Pevil-Ulysee and S S Mohan
      The Journal of Rheumatology April 1 2001, 28 (4) 874-875;
  8. Pozzi, M R

    1. You have access
      Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;

R

  1. Ravelli, A

    1. You have access
      Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
      A Ravelli, M C Caria, S Buratti, C Malattia, F Temporini and A Martini
      The Journal of Rheumatology April 1 2001, 28 (4) 865-867;
  2. Reboul, P

    1. You have access
      Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.
      D V Jovanovic, J A Di Battista, J Martel-Pelletier, P Reboul, Y He, F C Jolicoeur and J P Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 712-718;
    2. You have access
      Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone.
      J P Pelletier, D Lajeunesse, P Reboul, F Mineau, J C Fernandes, P Sabouret and J Martel-Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 814-824;
  3. Ritchlin, C

    1. You have access
      Expression of interleukin 10 mRNA and protein by synovial fibroblastoid cells.
      C Ritchlin and S A Haas-Smith
      The Journal of Rheumatology April 1 2001, 28 (4) 698-705;
  4. Romeu, J

    1. You have access
      Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
      E Casado, A Olivé, S Holgado, R Perez-Andres, J Romeu, J C Lorenzo, B Clotet and X Tena
      The Journal of Rheumatology April 1 2001, 28 (4) 802-804;

S

  1. Sabouret, P

    1. You have access
      Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone.
      J P Pelletier, D Lajeunesse, P Reboul, F Mineau, J C Fernandes, P Sabouret and J Martel-Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 814-824;
  2. Saevarsdottir, S

    1. You have access
      Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study.
      S Saevarsdottir, T Vikingsdottir, A Vikingsson, V Manfredsdottir, A J Geirsson and H Valdimarsson
      The Journal of Rheumatology April 1 2001, 28 (4) 728-734;
  3. Salvarini, C

    1. You have access
      Magnetic resonance imaging and polymyalgia rheumatica.
      C Salvarini, F Cantini, I Olivieri and G G Hunder
      The Journal of Rheumatology April 1 2001, 28 (4) 918-919;
  4. Samarkos, M

    1. You have access
      The clinical significance of IgA antiphospholipid antibodies.
      M Samarkos, R A Asherson and S Loizou
      The Journal of Rheumatology April 1 2001, 28 (4) 694-697;
  5. Saotome, K

    1. You have access
      Analysis of calcium deposits in calcific periarthritis.
      J Hamada, W Ono, K Tamai, K Saotome and T Hoshino
      The Journal of Rheumatology April 1 2001, 28 (4) 809-813;
  6. Saudan, A

    1. You have access
      Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;
  7. Schuster, E

    1. You have access
      Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;
  8. Segas, J V

    1. You have access
      How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study.
      K A Boki, J P Ioannidis, J V Segas, P V Maragkoudakis, D Petrou, G K Adamopoulos and H M Moutsopoulos
      The Journal of Rheumatology April 1 2001, 28 (4) 798-801;
  9. Seidel, W

    1. You have access
      Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;
  10. Shirazi, I

    1. You have access
      Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease.
      M Tishler, I Yaron, I Shirazi and M Yaron
      The Journal of Rheumatology April 1 2001, 28 (4) 795-797;
  11. Shlopov, B V

    1. You have access
      Regulation of cartilage collagenase by doxycycline.
      B V Shlopov, J M Stuart, M L Gumanovskaya and K A Hasty
      The Journal of Rheumatology April 1 2001, 28 (4) 835-842;
  12. Sinha, N

    1. You have access
      Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis.
      N K Tripathy, S Upadhyaya, N Sinha and S Nityanand
      The Journal of Rheumatology April 1 2001, 28 (4) 805-808;
  13. Sont, J K

    1. You have access
      High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis.
      R J Verburg, J K Sont, T P Vliet Vlieland, R B Landewé, M Boers, J Kievit and J M van Laar
      The Journal of Rheumatology April 1 2001, 28 (4) 719-727;
  14. Stabilini, R

    1. You have access
      Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;
  15. Strand, V

    1. You have access
      Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agenda.
      V Strand, M Lassere, D van der Heijde, K Johnson and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 887-889;
    2. You have access
      Minimal clinically important difference in plain films in RA: group discussions, conclusions, and recommendations. OMERACT Imaging Task Force.
      D van der Heijde, M Lassere, J Edmonds, J Kirwan, V Strand and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 914-917;
  16. Stuart, J M

    1. You have access
      Regulation of cartilage collagenase by doxycycline.
      B V Shlopov, J M Stuart, M L Gumanovskaya and K A Hasty
      The Journal of Rheumatology April 1 2001, 28 (4) 835-842;

T

  1. Takei, S

    1. You have access
      Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
      N Maeno, S Takei, H Imanaka, H Oda, K Yanagi, Y Hayashi and K Miyata
      The Journal of Rheumatology April 1 2001, 28 (4) 860-864;
  2. Talip, F

    1. You have access
      Treatment of Felty's syndrome with leflunomide.
      F Talip, N Walker, W Khan and B Zimmermann
      The Journal of Rheumatology April 1 2001, 28 (4) 868-870;
  3. Tamai, K

    1. You have access
      Analysis of calcium deposits in calcific periarthritis.
      J Hamada, W Ono, K Tamai, K Saotome and T Hoshino
      The Journal of Rheumatology April 1 2001, 28 (4) 809-813;
  4. Temporini, F

    1. You have access
      Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
      A Ravelli, M C Caria, S Buratti, C Malattia, F Temporini and A Martini
      The Journal of Rheumatology April 1 2001, 28 (4) 865-867;
  5. Tena, X

    1. You have access
      Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
      E Casado, A Olivé, S Holgado, R Perez-Andres, J Romeu, J C Lorenzo, B Clotet and X Tena
      The Journal of Rheumatology April 1 2001, 28 (4) 802-804;
  6. Tijhuis, G J

    1. You have access
      The value of a continuous ambulatory activity monitor to quantify the amount and intensity of daily activity in patients with rheumatoid arthritis.
      M Munneke, Z de Jong, A H Zwinderman, G J Tijhuis, J M Hazes and T P Vliet Vlieland
      The Journal of Rheumatology April 1 2001, 28 (4) 745-750;
  7. Tishler, M

    1. You have access
      Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease.
      M Tishler, I Yaron, I Shirazi and M Yaron
      The Journal of Rheumatology April 1 2001, 28 (4) 795-797;
  8. Tripathy, N K

    1. You have access
      Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis.
      N K Tripathy, S Upadhyaya, N Sinha and S Nityanand
      The Journal of Rheumatology April 1 2001, 28 (4) 805-808;
  9. Tröltzsch, M

    1. You have access
      Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;

U

  1. Upadhyaya, S

    1. You have access
      Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis.
      N K Tripathy, S Upadhyaya, N Sinha and S Nityanand
      The Journal of Rheumatology April 1 2001, 28 (4) 805-808;
  2. Urowitz, M B

    1. You have access
      Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus.
      D D Gladman, M B Urowitz, V Chaudhry-Ahluwalia, D C Hallet and R J Cook
      The Journal of Rheumatology April 1 2001, 28 (4) 761-765;

V

  1. Valdimarsson, H

    1. You have access
      Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study.
      S Saevarsdottir, T Vikingsdottir, A Vikingsson, V Manfredsdottir, A J Geirsson and H Valdimarsson
      The Journal of Rheumatology April 1 2001, 28 (4) 728-734;
  2. van der Heijde, D

    1. You have access
      Muhammad Asim Khan. Portrait of a rheumatologist as a great artist.
      A Boonen, D van der Heijde and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 843-844;
    2. You have access
      Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agenda.
      V Strand, M Lassere, D van der Heijde, K Johnson and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 887-889;
    3. You have access
      Foundations of the minimal clinically important difference for imaging.
      M N Lassere, D van der Heijde and K R Johnson
      The Journal of Rheumatology April 1 2001, 28 (4) 890-891;
    4. You have access
      Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials.
      M N Lassere, D van der Heijde, K R Johnson, M Boers and J Edmonds
      The Journal of Rheumatology April 1 2001, 28 (4) 892-903;
    5. You have access
      Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;
    6. You have access
      Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;
    7. You have access
      Minimal clinically important difference in plain films in RA: group discussions, conclusions, and recommendations. OMERACT Imaging Task Force.
      D van der Heijde, M Lassere, J Edmonds, J Kirwan, V Strand and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 914-917;
  3. van der Linden, S

    1. You have access
      Muhammad Asim Khan. Portrait of a rheumatologist as a great artist.
      A Boonen, D van der Heijde and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 843-844;
    2. You have access
      Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;
  4. van Laar, J M

    1. You have access
      High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis.
      R J Verburg, J K Sont, T P Vliet Vlieland, R B Landewé, M Boers, J Kievit and J M van Laar
      The Journal of Rheumatology April 1 2001, 28 (4) 719-727;
  5. Verburg, R J

    1. You have access
      High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis.
      R J Verburg, J K Sont, T P Vliet Vlieland, R B Landewé, M Boers, J Kievit and J M van Laar
      The Journal of Rheumatology April 1 2001, 28 (4) 719-727;
  6. Verhoeven, A

    1. You have access
      Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;
  7. Vikingsdottir, T

    1. You have access
      Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study.
      S Saevarsdottir, T Vikingsdottir, A Vikingsson, V Manfredsdottir, A J Geirsson and H Valdimarsson
      The Journal of Rheumatology April 1 2001, 28 (4) 728-734;
  8. Vikingsson, A

    1. You have access
      Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study.
      S Saevarsdottir, T Vikingsdottir, A Vikingsson, V Manfredsdottir, A J Geirsson and H Valdimarsson
      The Journal of Rheumatology April 1 2001, 28 (4) 728-734;
  9. Vliet Vlieland, T P

    1. You have access
      High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis.
      R J Verburg, J K Sont, T P Vliet Vlieland, R B Landewé, M Boers, J Kievit and J M van Laar
      The Journal of Rheumatology April 1 2001, 28 (4) 719-727;
    2. You have access
      The value of a continuous ambulatory activity monitor to quantify the amount and intensity of daily activity in patients with rheumatoid arthritis.
      M Munneke, Z de Jong, A H Zwinderman, G J Tijhuis, J M Hazes and T P Vliet Vlieland
      The Journal of Rheumatology April 1 2001, 28 (4) 745-750;

W

  1. Wagner, U

    1. You have access
      Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;
  2. Walker, N

    1. You have access
      Treatment of Felty's syndrome with leflunomide.
      F Talip, N Walker, W Khan and B Zimmermann
      The Journal of Rheumatology April 1 2001, 28 (4) 868-870;
  3. Wassmuth, R

    1. You have access
      Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;
  4. Waterloo, K

    1. You have access
      Somatic and psychological features of headache in systemic lupus erythematosus.
      R Omdal, K Waterloo, W Koldingsnes, G Husby and S I Mellgren
      The Journal of Rheumatology April 1 2001, 28 (4) 772-779;
  5. Widen, E

    1. You have access
      Familial systemic lupus erythematosus in Finland.
      S Koskenmies, E Widen, J Kere and H Julkunen
      The Journal of Rheumatology April 1 2001, 28 (4) 758-760;
  6. Wong, R W

    1. You have access
      Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
      C C Mok, C S Lau and R W Wong
      The Journal of Rheumatology April 1 2001, 28 (4) 766-771;
  7. Wordsworth, P

    1. You have access
      A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor.
      M Doran, P Wordsworth, B Bresnihan and O Fitzgerald
      The Journal of Rheumatology April 1 2001, 28 (4) 921-922;

Y

  1. Yanagi, K

    1. You have access
      Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
      N Maeno, S Takei, H Imanaka, H Oda, K Yanagi, Y Hayashi and K Miyata
      The Journal of Rheumatology April 1 2001, 28 (4) 860-864;
  2. Yaron, I

    1. You have access
      Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease.
      M Tishler, I Yaron, I Shirazi and M Yaron
      The Journal of Rheumatology April 1 2001, 28 (4) 795-797;
  3. Yaron, M

    1. You have access
      Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease.
      M Tishler, I Yaron, I Shirazi and M Yaron
      The Journal of Rheumatology April 1 2001, 28 (4) 795-797;

Z

  1. Zimmermann, B

    1. You have access
      Treatment of Felty's syndrome with leflunomide.
      F Talip, N Walker, W Khan and B Zimmermann
      The Journal of Rheumatology April 1 2001, 28 (4) 868-870;
  2. Zwinderman, A H

    1. You have access
      The value of a continuous ambulatory activity monitor to quantify the amount and intensity of daily activity in patients with rheumatoid arthritis.
      M Munneke, Z de Jong, A H Zwinderman, G J Tijhuis, J M Hazes and T P Vliet Vlieland
      The Journal of Rheumatology April 1 2001, 28 (4) 745-750;
Back to top
PreviousNext

In this issue

The Journal of Rheumatology
Vol. 28, Issue 4
1 Apr 2001
  • Table of Contents
  • Index by Author
  • Most Read
  • ​ Editor's Picks
  • E-letters
Loading
  • IgG4-related Disease With Destructive Nasal Bone Involvement Leading to Saddle Nose Deformity
  • Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan
  • Spondyloarthritis Among Patients With Uveitis: Can We Improve Referral Pathways?
  • Uveitis in Juvenile Psoriatic Arthritis: Still So Much To Learn
  • Getting the Diagnosis Right: What’s in a Name?
More...

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire